Advanced Medicine

41st Sysmex Scientific Seminar (Japan); Millennium Advanced Medicine Has Come a Long Way

The 41st Sysmex Scientific Seminar was held on June 9th, 2018 under the title “Millennium Advanced Medicine Has Come a Long Way”, based on the Millennium Project on Science and Technology initiated in Japan. The lectures covered a wide range of topics on regenerative medicine including iPS cell-based therapies for macular degeneration and Parkinson’s disease, combination of cell transplantation with gene tharapy, and regulatory T-Cells.

Videos

Disclaimer – The videos will be sent only by request.

1. Important issues in medical research started from the millennium project

Discussion of the impact of Science in Japan caused by the “Millenium Project”, which was initiated by the former Japanese Prime Minister K. Obuchi in 1999 to vitializescience and technology of Japan.

Professor HirooImura, M.D., Ph.D.Foundation for Biomedical Research and Innovation at Kobe, Kyoto University

2. Gene therapy comes of age: focusing on CAR-T cell therapy

Introduction of CD19-targeted CAR-T cell therapy approved by FDA in 2017 and progresses including application of genome editing technology to this novel therapy.

Professor Keiya Ozawa. Emeritus Professor and Visiting Professor Division of Immuno-Gene & Cell Therapy (Takara Bio)Jichi Medical University

3. Regulatory T cell: from the past to the present

Presentation of the history of the discovery of Regulatory T cells (Treg cells) along with the history of its function. The latter part of the lecture discusses the possibility of controlling immune response involving Treg cells from physiological and pathological perspectives.

Professor Shimon Sakaguchi, M.D., Ph.D.Immunology Frontier Research Center, Osaka University

4. Cell-based therapy for Parkinson’s disease

Discussion of the current status and prospects of induced pluripotent stem cell (iPSC) based therapy for Parkinson’s Disease.

Professor Jun Takahashi, M.D., Ph.D.Center for iPS Cell Research and Application (CiRA), Kyoto University Department of Clinical Application

5. Retinal regenerative medicine using iPS cells

Discussion of clinical application of therapies using retinal pigment epithelium (RPE) generated from pluripotent stem cells (embryonic stem cells [ESC], iPSC), and its potential for global pharmaceutical and related businesses.

Project Leader Masayo Takahashi, M.D., Ph.D.Laboratory for Retinal Regeneration RIKEN